There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Voriconazole is a broad-spectrum triazole that is active against aspergillus species.
We conducted a randomized trial to compare voriconazole with amphotericin B for primary
therapy of invasive aspergillosis.